Back to Search
Start Over
Exploring the interplay between autoimmunity and cancer to find the target therapeutic hotspots.
- Source :
-
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2018 Jun; Vol. 46 (4), pp. 658-668. Date of Electronic Publication: 2017 Jul 07. - Publication Year :
- 2018
-
Abstract
- Autoimmunity arises when highly active immune responses are developed against the tissues or substances of one's own body. It is one of the most prevalent disorders among the old-age population with prospects increasing with age. The major cause of autoimmunity and associated diseases is the dysregulation of host immune surveillance. Impaired repairment of immune system and apoptosis regulation can be seen as major landmarks in autoimmune disorders such as the mutation of p53 gene which results in rheumatoid arthritis, bowel disease which consequently lead to tissue destruction, inflammation and dysfunctioning of body organs. Cytokines mediated apoptosis and proliferation of cells plays a regulatory role in cell cycle and further in cancer development. Anti-TNF therapy, Treg therapy and stem cell therapy have been used for autoimmune diseases, however, with the increase in the use of immunomodulatory therapies and their development for autoimmune diseases and cancer, the understanding of human immune system tends to become an increasing requirement. Hence, the findings associated with the relationship between autoimmune diseases and cancer may prove to be beneficial for the improvement in the health of suffering patients. Here in, we are eliciting the underlying mechanisms which result in autoimmune disorders causing the onset of cancer, exploration of interactome to find the pathways which are mutual to both, and recognition of hotspots which might play important role in autoimmunity mediated therapeutics with different therapies such as anti-TNF therapy, Treg therapy and stem cell therapy.
- Subjects :
- Animals
Cytokines genetics
Cytokines immunology
Humans
T-Lymphocytes, Regulatory immunology
T-Lymphocytes, Regulatory pathology
Autoimmunity
Immunologic Surveillance
Immunotherapy methods
Mutation
Neoplasms genetics
Neoplasms immunology
Neoplasms pathology
Neoplasms therapy
Tumor Suppressor Protein p53 genetics
Tumor Suppressor Protein p53 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2169-141X
- Volume :
- 46
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Artificial cells, nanomedicine, and biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 28687059
- Full Text :
- https://doi.org/10.1080/21691401.2017.1350188